No TWEAK for COPD
نویسندگان
چکیده
References 1 Stone IS, Barnes NC, Petersen SE. Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease? Heart 2012; 98: 1055–1062. 2 McAllister DA, Maclay JD, Mills NL, et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176: 1208–1214. 3 Sabit R, Bolton CE, Edwards PH, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 1259–1265. 4 Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485–490. 5 Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105–1187. 6 Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55: 1318–1327. 7 Dransfield MT, Cockcroft JR, Townsend RR, et al. Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD. Respir Med 2011; 105: 1322–1330. 8 Vivodtzev I, Minet C, Wuyam B, et al. Significant improvement in arterial stiffness after endurance training in patients with COPD. Chest 2010; 137: 585–592. 9 Di Iorio BR, Cucciniello E, Alinei P, et al. Reproducibility of regional pulse-wave velocity in uremic subjects. Hemodial Int 2010; 14: 441–446. 10 Bode AS, Leermakers J, Kroon JW, et al. Determination of brachial artery stiffness prior to vascular access creation: reproducibility of pulse wave velocity assessment. Nephrol Dial Transplant 2012; 27: 2370–2376.
منابع مشابه
Tumor necrosis factor-like weak inducer of apoptosis regulates quadriceps muscle atrophy and fiber-type alteration in a rat model of chronic obstructive pulmonary disease
Background In chronic obstructive pulmonary disease (COPD), weakness and muscle mass loss of the quadriceps muscle has been demonstrated to predict survival and mortality rates of patients. Tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK), as a member of the TNF superfamily, has recently been identified as a key regulator of skeletal muscle wasting and metabolic dysfunction. S...
متن کاملThe effect of high-intensity exercise training on gene expression of tweak and Fn14 in EDL muscle of aged and adult mice
Muscle atrophy is one of the consequences of aging and sports activities may prevent it. The aim of this study was to evaluate the effect of high intensity interval training on gene expression of Tweak and Fn14 in EDL muscle of aged C57bl/6 mice. For this purpose, 28 male C57bl/6 mice aged (n=14) and adult (n=14) were assigned in two groups of training (n=7) and control (n=7). After one-week fa...
متن کاملThe effect of decreased physical activity on the expression of muscle atrophy-related genes after resistance, endurance and combined exercise training
Introduction and purpose: Decreased physical activity due to sciatic nerve ligation (SNL) cause muscle atrophy. The purpose of the present study was to investigate the effect of decreased physical activity in the form of spinal nerve ligation (SNL) on the expression of muscle atrophy-related genes (TWEAK and Fn14) after resistance, endurance and combined exercises. Materials and Methods: Thirty...
متن کاملTNF Receptor-Associated Factor 1 is a Major Target of Soluble TWEAK
Soluble tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK), in contrast to membrane TWEAK and TNF, is only a weak activator of the classical NFκB pathway. We observed that soluble TWEAK was regularly more potent than TNF with respect to the induction of TNF receptor-associated factor 1 (TRAF1), a NFκB-controlled signaling protein involved in the regulation of inflammatory signal...
متن کاملTWEAK/Fn14 and Non-Canonical NF-kappaB Signaling in Kidney Disease
The incidence of acute kidney injury (AKI) and chronic kidney disease (CKD) is increasing. However, there is no effective therapy for AKI and current approaches only slow down, but do not prevent progression of CKD. TWEAK is a TNF superfamily cytokine. A solid base of preclinical data suggests a role of therapies targeting the TWEAK or its receptor Fn14 in AKI and CKD. In particular TWEAK/Fn14 ...
متن کامل